awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38075117-CD78DFC1-FD04-46A2-9B7C-2DD4FF52495B
Q38075117-CD78DFC1-FD04-46A2-9B7C-2DD4FF52495B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075117-CD78DFC1-FD04-46A2-9B7C-2DD4FF52495B
Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus.
P2860
Q38075117-CD78DFC1-FD04-46A2-9B7C-2DD4FF52495B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38075117-CD78DFC1-FD04-46A2-9B7C-2DD4FF52495B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
059e7657a22ca9eaa1adf7464ba86cb05524d9e8
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.